Three other updates:
New COVID-19 cases are rising in 41 states and 17 states are reporting unprecedented surges, reports The New York Times. Record 7-day case averages were reported in 17 states, including Alaska, Minnesota, Montana and Wisconsin, which saw more new cases during the week ending Oct. 14 than any other week. Nine states are maintaining steady case numbers, and no state is seeing a sustained decline, according to the NYT.
Remdesivir does not significantly affect survival rates or length of stay for COVID-19 patients, according to preliminary results from a World Health Organization clinical trial involving 11,266 participants from 405 hospitals worldwide. The study was published in the preprint server medRXiv and has not been peer reviewed.
Pfizer will not apply for emergency use authorization of its COVID-19 vaccine candidate until the third week in November at the earliest, CEO Albert Bourla, PhD, said in an open letter Oct. 16.
Snapshot of COVID-19 in the U.S.
Cases: 7,981,009
Deaths: 217,717
Recovered: 3,177,397
Counts reflect data available as of 8:30 a.m. CDT Oct. 16.
More articles on public health:
COVID-19 death rates by state: Oct. 16
COVID-19 hospitalizations by state: Oct. 16
‘Superspreader’ party in New York tied to 37 COVID-19 cases; venue fined $12K
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
